Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard J Farrell

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Inflammatory Bowel Diseases|May 4, 2005
Immunogenicity of biological agents in inflammatory bowel diseaseDavid S Fefferman, Richard J Farrell
Paediatric Drugs|December 13, 2006
Recent advances in the understanding of celiac disease: therapeutic implications for the management of pediatric patientsJohn H Kwon, Richard J Farrell
Gastroenterology|December 14, 2005
Adding fuel to the fire: GM-CSF for active Crohn's diseaseAlan C Moss, Richard J Farrell
Inflammatory Bowel Diseases|October 12, 2004
Making sense of antisense: ISIS 2302 (alicaforsen) in the treatment of pouchitis. An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchitsDavid S Fefferman, Richard J Farrell
Lancet (London, England)|February 7, 2002
Ulcerative colitisRichard J Farrell, Mark A Peppercorn
Gastroenterology Clinics of North America|July 19, 2002
Microbial factors in inflammatory bowel diseaseRichard J Farrell, J Thomas LaMont
The American Journal of Gastroenterology|July 4, 2002
Equimolar doses of balsalazide and mesalamine: are we comparing apples and oranges?Richard J Farrell, Mark A Peppercorn
Gastroenterology|June 16, 2007
Impotent immune system: an underlying problem in Crohn's diseaseAlan C Moss, Richard J Farrell
Gastroenterology & Hepatology|October 1, 2011
ReviewMohammad Azam, Maire Buckley, Richard J Farrell
The American Journal of Managed Care|January 10, 2004
Celiac diseaseDaniel Leffler, Sumona Saha, Richard J Farrell
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Inflammatory Bowel Diseases|May 4, 2005
Immunogenicity of biological agents in inflammatory bowel diseaseDavid S Fefferman, Richard J Farrell
Paediatric Drugs|December 13, 2006
Recent advances in the understanding of celiac disease: therapeutic implications for the management of pediatric patientsJohn H Kwon, Richard J Farrell
Gastroenterology|December 14, 2005
Adding fuel to the fire: GM-CSF for active Crohn's diseaseAlan C Moss, Richard J Farrell
Inflammatory Bowel Diseases|October 12, 2004
Making sense of antisense: ISIS 2302 (alicaforsen) in the treatment of pouchitis. An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchitsDavid S Fefferman, Richard J Farrell
Lancet (London, England)|February 7, 2002
Ulcerative colitisRichard J Farrell, Mark A Peppercorn
Gastroenterology Clinics of North America|July 19, 2002
Microbial factors in inflammatory bowel diseaseRichard J Farrell, J Thomas LaMont
The American Journal of Gastroenterology|July 4, 2002
Equimolar doses of balsalazide and mesalamine: are we comparing apples and oranges?Richard J Farrell, Mark A Peppercorn
Gastroenterology|June 16, 2007
Impotent immune system: an underlying problem in Crohn's diseaseAlan C Moss, Richard J Farrell
Gastroenterology & Hepatology|October 1, 2011
ReviewMohammad Azam, Maire Buckley, Richard J Farrell
The American Journal of Managed Care|January 10, 2004
Celiac diseaseDaniel Leffler, Sumona Saha, Richard J Farrell
Pageof 4